WASHINGTON, D.C. — The FDA has given emergency use authorization for the Pfizer coronavirus vaccine to be given to children as young as 12 years old.
“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” said Acting FDA Commissioner Janet Woodcock, M.D. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”
In its announcement, the FDA said the vaccine was “at least as effective” in children as in adults, and that side-effects of the vaccine would be similar to what adults experience.